These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 26937365)
1. Expression of GLUT-1 in oral squamous cell carcinoma in tobacco and non-tobacco users. Azad N; Kumari Maurya M; Kar M; Goel MM; Singh AK; Sagar M; Mehrotra D; Kumar V J Oral Biol Craniofac Res; 2016; 6(1):24-30. PubMed ID: 26937365 [TBL] [Abstract][Full Text] [Related]
2. Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study. Panda A; Bandyopadhyay A; Mohiddin G; Raghuvanshi M; Sahoo SK; Bhuyan L Niger J Surg; 2019; 25(2):203-207. PubMed ID: 31579378 [TBL] [Abstract][Full Text] [Related]
3. [A preliminary study on the relationship between GLUT-1,MCT-4 and CAⅨ in laryngeal squamous cell carcinoma]. Wang YB; Xu O; Zhang RJ; Shan CG Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):510-514;519. PubMed ID: 29871299 [No Abstract] [Full Text] [Related]
4. Proliferative Index in Invasive Tumor Front of Oral Squamous Cell Carcinoma: A Potential Prognostic Indicator. Bhuyan L; Sarangi S; Das BK; Das SN; Nayak S J Contemp Dent Pract; 2018 Feb; 19(2):170-176. PubMed ID: 29422466 [TBL] [Abstract][Full Text] [Related]
5. Assessment of Serum Cortisol Levels in Patients with Oral Squamous Cell Carcinoma and Its Correlation with Clinical Staging, Histopathological Grading and Nodal Metastasis: A Prospective Study. Kalyani V; Rao G; Hatti P J Maxillofac Oral Surg; 2024 Aug; 23(4):843-855. PubMed ID: 39118919 [TBL] [Abstract][Full Text] [Related]
6. Glut-1 as a prognostic biomarker in oral squamous cell carcinoma. Harshani JM; Yeluri S; Guttikonda VR J Oral Maxillofac Pathol; 2014; 18(3):372-8. PubMed ID: 25948991 [TBL] [Abstract][Full Text] [Related]
15. HIF-1α and GLUT-1 Expression in Atypical Endometrial Hyperplasia, Type I and II Endometrial Carcinoma: A Potential Role in Pathogenesis. Al-Sharaky DR; Abdou AG; Wahed MM; Kassem HA J Clin Diagn Res; 2016 May; 10(5):EC20-7. PubMed ID: 27437226 [TBL] [Abstract][Full Text] [Related]
16. Study of expression of GLUT-1 in oral potentially malignant disorders and oral squamous cell carcinoma: An immuno-histochemical analysis. Attur SK; Patel A; Attur KM J Oral Maxillofac Pathol; 2024; 28(1):70-76. PubMed ID: 38800421 [TBL] [Abstract][Full Text] [Related]
17. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Tian M; Zhang H; Nakasone Y; Mogi K; Endo K Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material. Weiner MF; Miranda RN; Bardales RH; Mukunyadzi P; Baker SJ; Korourian S; De Las Casas LE Diagn Cytopathol; 2004 Nov; 31(5):294-9. PubMed ID: 15468132 [TBL] [Abstract][Full Text] [Related]
19. Expression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancer. Luczynska E; Gasinska A; Wilk W Pol J Pathol; 2012 Dec; 63(4):272-7. PubMed ID: 23359198 [TBL] [Abstract][Full Text] [Related]
20. Glucose transporter-1 expression in squamous cell carcinoma of the tongue. Choi YS; Kim SJ; Kim DS; Park SJ; Park Y; Shin HJ; Jung KY; Baek SK; Shin BK; Choi JW; Kim BS; Shin SW; Kim YH; Kim JS Cancer Res Treat; 2007 Sep; 39(3):109-15. PubMed ID: 19746220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]